PTC Therapeutics PTCT Sale of investments
Sale of investments at other companies
Other financials
Where this comes from
Reported directly by PTC Therapeutics in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleOfAvailableForSaleSecuritiesDebt.
The official record: PTC Therapeutics’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about PTC Therapeutics's sale of investments.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is PTC Therapeutics's sale of investments?
- PTC Therapeutics (PTCT) reported sale of investments of $376.36M in Q1 2026.
- How has PTC Therapeutics's sale of investments changed year-over-year?
- PTC Therapeutics's sale of investments increased by 175.2% year-over-year, from $136.75M to $376.36M.
- What is the long-term trend for PTC Therapeutics's sale of investments?
- Over 3 years (2021 to 2025), PTC Therapeutics's sale of investments has grown at a -2.4% compound annual growth rate (CAGR), from $843.5M to $783.9M.
- What does sale of investments mean?
- This represents cash inflows from the sale of marketable securities, such as corporate bonds or government debt, classified as available-for-sale. It reflects the company's active management of its liquid investment portfolio.